Recently, the “National Grassroots Diabetes Prevention and Management Guidelines (2022)” (hereinafter referred to as “New Guidelines”) jointly formulated by the Diabetes Branch of the Chinese Medical Association and the National Grassroots Diabetes Prevention and Management Office was officially released. Jinlida Granules are recommended for the treatment of type 2 diabetes.
National Grassroots Diabetes Prevention and Management Guidelines (2022)
In recent years, the prevalence of diabetes among adults in my country has continued to rise, reaching 11.9%, but the national diabetes awareness rate, treatment rate and control rate are all low. Prevention and control work is the main battlefield, and the task of prevention and control is arduous. For the first time, the “New Edition Guidelines” adds the chapter “Traditional Chinese Medicine for Diabetes Prevention and Control”, actively supports and encourages the integration of traditional Chinese medicine into the comprehensive diabetes prevention and control system, gives full play to the advantages of holistic view, syndrome differentiation and treatment, combines physical constitution identification, etc., and comprehensively uses various methods such as drugs and non-drugs. Comprehensive prevention and treatment. The guidelines make it clear that in terms of synergistic sugar control and symptom improvement, it is recommended that patients with type 2 diabetes can use Jinlida granules in combination with conventional treatment.
Jinlida granule is an innovative traditional Chinese medicine with multi-component, multi-target and multi-action mechanism. specialty. Studies have confirmed that Jinlida Granules combined with metformin and other oral hypoglycemic drugs or insulin can play a synergistic role in controlling blood sugar, regulating glucose and lipid metabolism, protecting islet beta cells, improving insulin resistance, improving blood sugar fluctuations, and delaying complications. Advantage. Jinlida Granules can reduce blood sugar while taking into account the complications. The treatment of patients is holistic and comprehensive, and can be used for the prevention and treatment of prediabetes, type 2 diabetes and diabetes complications.
A number of randomized controlled clinical studies and meta-analyses have confirmed the role of Jinlida Granules in the prevention and treatment of diabetes:
- Jinlida Granules are used for prediabetes , can improve abnormal glucose tolerance and reduce the risk of type 2 diabetes;
- Jinlida granules are used for type 2 diabetes, It can stably lower blood sugar, promote compliance, slow down the occurrence of complications, and improve symptoms such as dry mouth, thirst, constipation, fatigue, etc.;
- Jinlida Granules are used for Diabetes complicated with abnormal lipid metabolism or (and) obesity can improve abnormal lipid metabolism, increase brown fat activity, reduce white fat accumulation, and reduce body weight;
- jinli Da granule for chronic complications of diabetes can reduce urinary microalbumin, reduce early diabetic kidney damage; protect blood vessels and reduce the incidence of cardiovascular events; increase nerve conduction velocity and improve diabetic peripheral neuropathy patients Numbness pain symptoms.
Based on the significant curative effect and sufficient research evidence of Jinlida granules in the prevention and treatment of diabetes, it has been successively approved by the “Guidelines for Clinical Evidence-Based Practice of Diabetes TCM” and “Traditional Chinese Medicine Clinical Diagnosis and Treatment of Diabetic Peripheral Neuropathy”. Guidelines, Guidelines for Clinical Application of Chinese Proprietary Medicines – Diabetes Volume, Expert Consensus on Clinical Drugs for Diabetic Microcirculation Disorders, China Guidelines for the Prevention and Treatment of Type 2 Diabetes (2017/2020 Version), and Clinical Differentiation and Treatment of Traditional Chinese Medicine, etc. Textbooks are listed as recommended drugs. In addition, “Standardized Research on Combined Application of Chinese and Western Medicine with Jinlida Granules as Demonstration” won the second prize of Science and Technology Award of Chinese Association of Chinese Medicine in 2019. It fully reflects the important role of Jinlida granules in the clinical treatment of type 2 diabetes, and further demonstrates the academic value of TCM collateral disease theory in the field of diabetes prevention and treatment.
It is reported that the “New Guide” compiled by Professor Jia Weiping, an academician of the Chinese Academy of Engineering, is an update based on the 2018 guide and the latest progress in domestic and foreign research practices. The chapter “Traditional Chinese Medicine for Diabetes Prevention”, which was added for the first time in content, was jointly formulated by Professor Yang Shuyu, Director of the Grassroots Diabetes Prevention and Control Expert Steering Committee of the Chinese Association of Traditional Chinese Medicine, and organized by experts in diabetes-related fields and grassroots medical and health TCM and Western medicine, aiming to further promote grassroots diabetes health management. Homogenization and normalization.